Qiagen Forecast, price target & analysts
Why the stock moved Beta
Qiagen Target price 2026 - Analyst rating & recommendation
Qiagen Classifications & Recommendation
Qiagen Price Target
| Target Price | €40.62 |
| Price | €38.61 |
| Potential | 5.23% |
| Number of Estimates | 18 |
| 18 Analysts have issued a price target Qiagen 2027 . The average Qiagen target price is €40.62. This is 5.23% higher than the current stock price. The highest price target is €47.27 22.45% , the lowest is €34.98 9.39% . | |
| A rating was issued by 23 analysts: 11 Analysts recommend Qiagen to buy, 12 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Qiagen stock has an average upside potential 2027 of 5.23% . Most analysts recommend the Qiagen stock at Hold. |
Sales and Margin forecast 2026, 2027 to 2030
24 Analysts have issued a sales forecast Qiagen 2026 . The average Qiagen sales estimate is
This results in the following potential growth metrics:
22 Analysts have issued an Qiagen EBITDA forecast 2026. The average Qiagen EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
24 Qiagen Analysts have issued a net profit forecast 2026. The average Qiagen net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030
24 Analysts have issued a Qiagen forecast for earnings per share. The average Qiagen EPS is
This results in the following potential growth metrics and future valuations:
Current Qiagen Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| UBS |
Neutral
➜
Neutral
|
Unchanged | Sep 09 2026 |
| Citigroup |
Neutral
➜
Neutral
|
Unchanged | Aug 10 2026 |
| Barclays |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Aug 07 2026 |
| JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Aug 07 2026 |
| Morgan Stanley |
Equal-Weight
➜
Overweight
|
Upgrade | Jun 23 2026 |
| Stifel |
Hold
➜
Hold
|
Unchanged | May 18 2026 |
| TD Cowen |
Hold
➜
Hold
|
Unchanged | May 07 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
UBS:
Neutral
➜
Neutral
|
Sep 09 2026 |
|
Unchanged
Citigroup:
Neutral
➜
Neutral
|
Aug 10 2026 |
|
Unchanged
Barclays:
Equal-Weight
➜
Equal-Weight
|
Aug 07 2026 |
|
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Aug 07 2026 |
|
Upgrade
Morgan Stanley:
Equal-Weight
➜
Overweight
|
Jun 23 2026 |
|
Unchanged
Stifel:
Hold
➜
Hold
|
May 18 2026 |
|
Unchanged
TD Cowen:
Hold
➜
Hold
|
May 07 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
